Efficacy and safety of the novel oral factor Xa inhibitor apixaban in atrial fibrillation (AF) patients with chronic kidney disease (CKD): the AVERROES trial

被引：0
|
作者：
Hart, R. G. [1 ]
Eikelboom, J. [2 ]
Yusuf, S. [3 ]
Gao, P. [3 ]
Paolasso, E. [4 ]
De Caterina, R. [5 ]
Husted, S. [6 ]
Connolly, S. J. [2 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[2] McMaster Univ, Hamilton, ON, Canada
[3] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada
[4] Inst Cardiovasc Rosario, Rosario, Santa Fe, Argentina
[5] Univ Cardiol Div Chieti, Chieti, Italy
[6] Aarhus Univ, Aarhus, Denmark
来源：
EUROPEAN HEART JOURNAL | 2011年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6 / 6
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of Apixaban in Patients With Atrial Fibrillation According to Sex: Results From the ARISTOTLE Trial
    Vinereanu, Dragos
    Stevens, Susanna R.
    Alexander, John H.
    Al-Khatib, Sana M.
    Avezum, Alvaro
    Bahit, Cecilia
    Granger, Christopher B.
    Lopes, Renato D.
    Halvorsen, Sigrun
    Hanna, Michael
    Husted, Steen
    Hylek, Elaine M.
    Margulescu, Andrei D.
    Wallentin, Lars
    Atar, Dan
    [J]. CIRCULATION, 2013, 128 (22)
  • [32] Oral anticoagulation therapy in atrial fibrillation patients with advanced chronic kidney disease: CODE-AF Registry
    Park, H.
    Yu, H. T.
    Kim, T. H.
    Park, J.
    Park, J. K.
    Kang, K. W.
    Shim, J.
    Kim, J. B.
    Choi, E. K.
    Park, H. W.
    Lee, Y. S.
    Joung, B.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 628 - 628
  • [33] Oral Anticoagulation Therapy in Atrial Fibrillation Patients with Advanced Chronic Kidney Disease: CODE-AF Registry
    Park, Hanjin
    Yu, Hee Tae
    Kim, Tae-Hoon
    Park, Junbeom
    Park, Jin-Kyu
    Kang, Ki-Woon
    Shim, Jaemin
    Kim, Jin-Bae
    Kim, Jun
    Choi, Eue-Keun
    Park, Hyung Wook
    Lee, Young Soo
    Joung, Boyoung
    [J]. YONSEI MEDICAL JOURNAL, 2023, 64 (01) : 18 - 24
  • [34] Safety and Efficacy of Apixaban Versus Warfarin in Patients With Advanced Chronic Kidney Disease
    Schafer, Joseph H.
    Casey, Ashley L.
    Dupre, Kristina A.
    Staubes, Britta A.
    [J]. ANNALS OF PHARMACOTHERAPY, 2018, 52 (11) : 1078 - 1084
  • [35] Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial
    Hu, Peter T.
    Lopes, Renato D.
    Stevens, Susanna R.
    Wallentin, Lars
    Thomas, Laine
    Alexander, John H.
    Hanna, Michael
    Lewis, Basil S.
    Verheugt, Freek W. A.
    Granger, Christopher B.
    Jones, W. Schuyler
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (01):
  • [36] INFLAMMATION IS A NOVEL RISK FACTOR FOR ATRIAL FIBRILLATION IN CHRONIC KIDNEY DISEASE
    Raj, Dominic S.
    Amdur, Richard
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 159 - 159
  • [37] Oral Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease
    Stoica, Mihai Ciprian
    Gall, Zsolt
    Gliga, Mirela Liana
    Caldararu, Carmen Denise
    Szekely, Orsolya
    [J]. MEDICINA-LITHUANIA, 2021, 57 (05):
  • [38] Direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease
    Ozbek, Kerem
    Cicekcioglu, Huelya
    Cetin, Mustafa
    Duyuler, Pinar Turker
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2020, 43 (02): : 266 - 266
  • [39] Oral anticoagulation with coumarins for patients with atrial fibrillation and chronic kidney disease?
    Walter H. Hörl
    [J]. Wiener klinische Wochenschrift, 2009, 121 : 668 - 672
  • [40] Oral Anticoagulant Treatment of Atrial Fibrillation in Chronic Kidney Disease Patients
    Artan, Ayse Serra
    Gursu, Meltem
    Elcioglu, Omer Celal
    Kazancioglu, Rumeyza
    [J]. TURKISH JOURNAL OF NEPHROLOGY, 2019, 28 (03): : 208 - 215
12345